PHARMA & LIFE SCIENCES: LATEST INTERVIEWS MORE INTERVIEWS
Ocugen explains its work on cures for unmet needs in the ophthalmology space and COVID-19 vaccine development.
Famar explains how it will continue develop capabilities so as to accompany its customers through clinical phases with clinical batches, scale-up, and ultimately manufacturing and packaging.
Tosk explains how it is successfully developing drugs to counter the side effects of cancer therapies.
Lonza Capsules and Health Ingredients comments on market trends.
PHARMA & LIFE SCIENCES: LATEST ARTICLES
Funding Environment: Life Sciences Enter the Mainstream
April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.
Turkey Pharmaceuticals: Bringing All Actors Together
June 17, 2020
Industry, university, investors - the two-way bridge to the knowledge gap.
PHARMA & LIFE SCIENCES: RECENTLY RELEASED PUBLICATIONS
MACIG
SUBSCRIBE TO OUR NEWSLETTER
RECENTLY PUBLISHED
United States Pharmaceuticals & Biopharmaceuticals 2021
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
